Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Positron Emission Tomography
54%
Fluorodeoxyglucose F 18
50%
Positron Emission Tomography
46%
Infection
46%
Diagnosis
34%
Nuclear Medicine
27%
Radioactive Tracer
23%
Fluorine-18
21%
Scintigraphy
19%
Leukocyte
19%
Neoplasm
18%
Molecular Imaging
17%
Systematic Review
15%
Estrogen Receptor
14%
Diagnostic Accuracy
14%
Disease
13%
Imaging Technique
13%
Vasculitis
13%
Breast Cancer
12%
Metastatic Breast Cancer
11%
Diethylstilbestrol
11%
Computer Assisted Tomography
10%
Inflammatory Disorder
9%
Polyethylene Terephthalate
9%
Technetium-99
9%
Meta-Analysis
9%
Amyloidosis
8%
Bone Scintigraphy
8%
Osteomyelitis
8%
Magnetic Resonance Imaging
7%
Metastatic Carcinoma
7%
Infective Endocarditis
7%
Giant-Cell Arteritis
7%
Fluorodeoxyglucose
7%
Cardiovascular System
7%
Prosthetics
6%
Image Quality
6%
Radiopharmaceutical Agent
6%
Blood Vessel Graft
6%
Single-Photon Emission Computed Tomography
6%
Treatment Response
6%
Biopsy
6%
Diabetic Foot
5%
Nuclear Imaging
5%
COVID-19
5%
Heart Amyloidosis
5%
Diagnostic Performance
5%
Posttransplant Lymphoproliferative Disease
5%
Polymyalgia Rheumatica
5%
Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
29%
18F-FDG PET-CT
12%
Positron Emission Tomography
11%
18F-fluorodeoxyglucose (18F-FDG)
8%
Nuclear Medicine
8%
Long Axial Field of View PET
8%
Nuclear Imaging
6%
Whole-body
6%
Fluorodeoxyglucose
6%
Fracture-related Infection
6%
Inflammation
6%
Metastatic Breast Cancer
6%
Diagnostic Accuracy
5%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
5%
PET Imaging
5%
Molecular Imaging
5%
Estrogen Receptor
5%
